MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$153,390K
Net Income
-$4,385K
Net Profit Margin
-2.86%
EPS
-$0.31
Unit: Thousand (K) dollars
Revenue Breakdown
United states
International
Revenue Breakdown
Vte
Emerging therapies
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2024-09-30
Revenue
153,390
Cost of goods sold
19,846
Gross profit
133,544
Research and development
29,431
Amortization of intangible asset
2,504
Change in fair value of contingent consideration
6,578
Selling, general and administrative
108,271
Acquisition-related expenses
328
Total operating expenses
147,112
(loss) income from operations
-13,568
Other expense
-130
Interest expense
78
Interest income
1,104
Total other income
896
(loss) income before income taxes
-12,672
Provision for income taxes
5,695
Net (loss) income
-18,367
Unrealized gain (loss) on available-for-sale debt securities
64
Foreign currency translation adjustments
13,918
Total other comprehensive income (loss)
13,982
Comprehensive income (loss)
-4,385
Basic EPS
-0.31
Diluted EPS
-0.31
Basic Average Shares
58,366,364
Diluted Average Shares
58,366,364
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Foreign currency
translation adjustments
$13,918K
Unrealized gain (loss) on
available-for-sale debt securities
$64K
Comprehensive income (loss)
-$4,385K
Total other
comprehensive income (loss)
$13,982K
Net (loss) income
-$18,367K
Interest income
$1,104K
United states
$141,854K
International
$11,536K
(loss) income before
income taxes
-$12,672K
Provision for income taxes
$5,695K
Total other income
$896K
Revenue
$153,390K
Other expense
-$130K
Interest expense
$78K
(loss) income from
operations
-$13,568K
Gross profit
$133,544K
Cost of goods sold
$19,846K
Total operating
expenses
$147,112K
Selling, general and
administrative
$108,271K
Research and development
$29,431K
Change in fair value of
contingent consideration
$6,578K
Amortization of intangible
asset
$2,504K
Acquisition-related expenses
$328K
Buy us a coffee
null (NARI)
null (NARI)